Balyasny Asset Management LLC Exact Sciences Corp Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 12,300 shares of EXAS stock, worth $688,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,300

Previous 325,668 96.22%

Holding current value

$688,554

Previous $13.8 Million 93.92%

% of portfolio

0.0%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $18 Million - $32.3 Million	-435,177 Reduced 57.2%	325,668 $13.8 Million
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $42.4 Million - $55.6 Million	754,323 Added 11565.82%	760,845 $52.5 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $48,488 - $62,166	-821 Reduced 11.18%	6,522 $482,000
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $14.9 Million - $22.3 Million	-225,587 Reduced 96.85%	7,343 $500,000
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $9.27 Million - $14.1 Million	147,954 Added 174.11%	232,930 $21.9 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $51 Million - $76.5 Million	-1,081,433 Reduced 92.71%	84,976 $5.76 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $35.4 Million - $62 Million	1,166,409 New	1,166,409 $57.7 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $958,656 - $2.05 Million	26,921 Added 463.44%	32,730 $1.29 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $524,204 - $720,606	5,809 New	5,809 $554,000
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $24.1 Million - $35.8 Million	-257,195 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $30 Million - $39.9 Million	257,195 New	257,195 $33.9 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $2.75 Million - $3.84 Million	-37,687 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $2.1 Million - $3.5 Million	37,687 New	37,687 $3.28 Million
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $394,557 - $729,472	-10,427 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $50,690 - $73,235	-1,273 Reduced 10.88%	10,427 $421,000
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $125,523 - $163,377	-2,700 Reduced 18.75%	11,700 $615,000
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $533,520 - $678,528	14,400	14,400 $679,000

Others Institutions Holding EXAS

# of Institutions

667

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.91B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Exact Sciences Corp Transaction History